| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1049965636 |
| P356 | DOI | 10.1007/BF00686477 |
| P953 | full work available at URL | http://link.springer.com/content/pdf/10.1007/BF00686477.pdf |
| http://link.springer.com/article/10.1007/BF00686477/fulltext.html | ||
| http://link.springer.com/content/pdf/10.1007/BF00686477 | ||
| P698 | PubMed publication ID | 1316809 |
| P2093 | author name string | H. Okamoto | |
| T. Tamura | |||
| Y. Ohe | |||
| Y. Sasaki | |||
| K. Eguchi | |||
| A. Kojima | |||
| T. Miya | |||
| T. Shinkai | |||
| F. Oshita | |||
| K. Iemura | |||
| P2860 | cites work | Journal of the National Cancer Institute | Q400279 |
| Effect of alternating combination chemotherapy on survival of ambulatory patients with metastatic large-cell and adenocarcinoma of the lung. A Southwest Oncology Group Study | Q70134756 | ||
| Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapy | Q72893140 | ||
| The effect of bronchitis, smoking, and occupation on ventilation | Q76455131 | ||
| Nonparametric Estimation from Incomplete Observations | Q25938997 | ||
| The American Review of Respiratory Disease | Q26839505 | ||
| Cancer Treatment Reports | Q27710285 | ||
| Cisplatin and vindesine combination chemotherapy for non-small cell lung cancer: a randomized trial comparing two dosages of cisplatin | Q33445456 | ||
| 352. Note: Conservatism of the Approximation Σ(O - E) 2 /E in the Logrank Test for Survival Data or Tumor Incidence Data | Q36530107 | ||
| Therapy with cisplatin and etoposide for non-small-cell lung cancer | Q39504917 | ||
| Brief overview of combination chemotherapy in non-small-cell lung cancer. | Q39504968 | ||
| A new international staging system for lung cancer | Q39729989 | ||
| Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study | Q39788280 | ||
| Chemotherapy for adenocarcinoma of the lung (WHO III): A randomized study of vindesine versus lomustine, cyclophosphamide, and methotrexate versus all four drugs | Q41318956 | ||
| Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy | Q41346693 | ||
| Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial | Q42152501 | ||
| Prognostic factors in non-small cell lung cancer: multiregression analysis in the National Cancer Center Hospital (Japan). | Q48260298 | ||
| Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer. | Q48459629 | ||
| Outcome of patients with small-cell lung cancer: effect of changes in staging procedures and imaging technology on prognostic factors over 14 years | Q48961924 | ||
| Prognostic factors for survival in patients with inoperable lung cancer. | Q52759758 | ||
| Prognostic factors in inoperable adenocarcinoma of the lung: a multivariate regression analysis of 259 patients. | Q53408079 | ||
| Regression models for prognostic prediction: advantages, problems, and suggested solutions. | Q53722887 | ||
| Estimation of the Probability of an Event as a Function of Several Independent Variables | Q56170484 | ||
| A randomised clinical trial of vindesine plus cisplatin versus mitomycin plus vindesine and cisplatin in advanced non-small cell lung cancer | Q68241117 | ||
| A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer | Q68857547 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lung cancer | Q47912 |
| oncology | Q162555 | ||
| cancer research | Q3421914 | ||
| P304 | page(s) | 1-6 | |
| P577 | publication date | 1992-01-01 | |
| P1433 | published in | Cancer Chemotherapy and Pharmacology | Q326137 |
| P1476 | title | A prognostic-factor risk index in advanced non-small-cell lung cancer treated with cisplatin-containing combination chemotherapy | |
| P478 | volume | 30 |
| Q40560871 | A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors |
| Q44132887 | Biological variables and stratification of patients with inoperable non-small-cell bronchial cancer: recommendations for future trials |
| Q55209541 | Correlation of gene-specific damage with cisplatin between human adenocarcinoma cells and peripheral blood mononuclear cells analyzed by polymerase chain reaction-stop assay. |
| Q77068399 | Does treatment delay affect survival in non-small cell lung cancer? A retrospective analysis from a single UK centre |
| Q40789832 | Enhancement of in vivo antitumor activity of a novel antimitotic 1-phenylpropenone derivative, AM-132, by tumor necrosis factor-alpha or interleukin-6. |
| Q41211903 | Gender influence on weight-loss pattern and survival of nonsmall cell lung carcinoma patients |
| Q64950980 | Preoperative anemia as a prognostic factor in patients with lung cancer: a systematic review and meta-analysis of epidemiological studies. |
| Q44386107 | Pretreatment clinical prognostic factors in patients with stage IV non-small cell lung cancer (NSCLC) treated with chemotherapy |
| Q41523310 | Pretreatment minimal staging and prognostic factors for non-small cell lung cancer |
| Q55066021 | Prognostic factors for short-term survival in patients with stage IV non-small cell lung cancer. |
| Q71842951 | Serum albumin and other prognostic factors related to response and survival in patients with advanced non-small cell lung cancer |
| Q78022266 | [Survival time of exclusively irradiated NSCLC patients: the viewpoint of a clinical biologist. Concerning the article by R. Wilhelm et al in Strahlenther Onkol 1988: 174:128-32 (No. 3)] |
Search more.